Independent, evidence-based guides to Ozempic, Wegovy, Mounjaro, and every GLP-1 drug on the market. No pharmaceutical sponsors. No sales pitch. Just the information you actually need.
100%
Independent
Evidence
Based Content
$0
Pharma Sponsors
2026
Updated Info
The FDA just approved Wegovy HD — semaglutide at 7.2mg, triple the standard dose. With 20.7% mean weight loss, it closes the gap with tirzepatide. Here's everything you need to know.
Retatrutide, orforglipron, CagriSema, aleniglipron — the next generation of obesity medications is closer than you think. Here's what's in the pipeline and when to expect it.
Some people report improved sexual function on GLP-1 medications. Others report the opposite. The research explains why both experiences are valid — and what drives the difference.
The first GLP-1 pill for weight loss is here. Oral semaglutide launched in January 2026 at $149-$299/month. Here's how it works, what to expect, and how it compares to the injection.
PCOS and obesity are deeply intertwined, and GLP-1 medications may help with both. Here's what the research says about semaglutide, tirzepatide, and polycystic ovary syndrome.
People on GLP-1 medications are reporting they've lost interest in cigarettes alongside food cravings. Early research suggests this isn't coincidence — the same brain pathways are involved.
The two dominant molecules in GLP-1 therapy compared head-to-head. How do tirzepatide and semaglutide differ in mechanism, weight loss, side effects, cost, and availability in 2026?
Both contain semaglutide, but Ozempic and Wegovy are approved for different purposes, come in different doses, and cost different amounts. Here's the complete comparison for 2026.
Both FDA-approved specifically for weight loss, Wegovy and Zepbound represent the two leading options in 2026. Here's how they compare on every metric that matters.
The two biggest names in GLP-1 medications go head-to-head. How do Ozempic and Mounjaro compare on weight loss, side effects, cost, and mechanism of action in 2026?
Weekly insights on GLP-1 medications, nutrition tips, new drug updates, and real stories from real people. Trusted by thousands. Free forever.
No spam. Unsubscribe anytime. We respect your privacy.
We're not a pharmaceutical company. We're not a telehealth clinic trying to sell you a prescription. We're an independent health resource built by people who understand both the science and the real-world experience of GLP-1 medications.
Every article is researched against peer-reviewed studies and clinical data. We cite our sources. We update our content when new evidence emerges. And we never let advertising influence our recommendations.
Learn more about us →